Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 1.00 |
| ▸ | PPARG | P37231 | 6/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 4/20 | 1.00 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 1.00 |
| ▸ | RXRA | P19793 | 2/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.77 |
| ▸ | F7 | P08709 | 4/20 | 0.77 |
| ▸ | F3 | P13726 | 4/20 | 0.77 |
| ▸ | PPARD | Q03181 | 4/20 | 0.77 |
| ▸ | PPARA | Q07869 | 4/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Doconexent SCHEMBL18274946 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL2241832 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185529 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185428 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL288437 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL17289459 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185531 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL13900774 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185505 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL12073579 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111351870-A | Irritable bowel syndrome serum metabolism marker combination and diagnostic kit thereof | 康美华大基因技术有限公司 | 2020-06-30 | — | — | CN | claimed |
| WO-2020079223-A1 | LIPOXYGENASE-CATALYZED PRODUCTION OF UNSATURATED C10-ALDEHYDES FROM POLYUNSATURATED FATTY ACIDS (PUFA) | FIRMENICH SA (CH) | 2020-04-23 | — | — | WO | claimed |
| CN-120053660-A | Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120053661-A | Hydrophilic fatty acid complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119855607-A | Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application | 太阳雨林(北京)生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| CN-115607677-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-114788872-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-114569726-A | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-111351870-A | Irritable bowel syndrome serum metabolism marker combination and diagnostic kit thereof | 康美华大基因技术有限公司 | 2020-06-30 | — | — | CN | disclosed |
| WO-2020079223-A1 | LIPOXYGENASE-CATALYZED PRODUCTION OF UNSATURATED C10-ALDEHYDES FROM POLYUNSATURATED FATTY ACIDS (PUFA) | FIRMENICH SA (CH) | 2020-04-23 | — | — | WO | disclosed |
| US-20200085774-A1 | Omega-3 Fatty Acid Composition for Preventing and/or Treating Cachexia | PRONOVA BIOPHARMA NORGE AS (NO) | 2020-03-19 | — | — | US | disclosed |
| EP-3558292-A1 | OMEGA-3 FATTY ACID COMPOSITION FOR PREVENTING AND/OR TREATING CACHEXIA | BASF AS (NO) | 2019-10-30 | — | — | EP | disclosed |
| WO-2018115459-A1 | OMEGA-3 FATTY ACID COMPOSITION FOR PREVENTING AND/OR TREATING CACHEXIA | PRONOVA BIOPHARMA NORGE AS (NO) | 2018-06-28 | — | — | WO | disclosed |
| JP-2005023028-A | SEAWEED EXTRACT CONTAINING CELL-ACTIVATING MATERIAL AND METHOD FOR PRODUCING THE SAME | KOCHI PREFECTURE | 2005-01-27 | — | — | JP | disclosed |